BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1897026)

  • 1. Immune responses elicited by transplantation and tissue-restricted antigens expressed on retinal tissues implanted subconjunctivally.
    Jiang LQ; Streilein JW
    Transplantation; 1991 Sep; 52(3):513-9. PubMed ID: 1897026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity and immune privilege elicited by autoantigens expressed on syngeneic neonatal neural retina grafts.
    Jiang LQ; Streilein JW
    Curr Eye Res; 1992 Jul; 11(7):697-709. PubMed ID: 1521470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
    Jiang LQ; Streilein JW
    Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3347-54. PubMed ID: 8225870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that retinal pigment epithelium functions as an immune-privileged tissue.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3467-73. PubMed ID: 11006240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney.
    Ng TF; Osawa H; Hori J; Young MJ; Streilein JW
    J Immunol; 2002 Nov; 169(10):5601-6. PubMed ID: 12421938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unconventional rejection of neural retinal allografts implanted into the immunologically privileged site of the eye.
    Jiang LQ; Jorquera M; Streilein JW; Ishioka M
    Transplantation; 1995 Apr; 59(8):1201-7. PubMed ID: 7732567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants.
    Grisanti S; Ishioka M; Kosiewicz M; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1619-26. PubMed ID: 9224290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts.
    Ma N; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2384-93. PubMed ID: 9804147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
    Wang M; Yoshida A; Kawashima H; Ishizaki M; Takahashi H; Hori J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1522-32. PubMed ID: 16565388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
    Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
    J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology and privilege of neuronal retina and pigment epithelium transplants.
    Streilein JW; Ma N; Wenkel H; Ng TF; Zamiri P
    Vision Res; 2002 Feb; 42(4):487-95. PubMed ID: 11853765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune privilege of allogeneic neuroretinal transplants in the subconjunctival space.
    Ghosh F; Rauer O; Arnér K
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1715-22. PubMed ID: 18751716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell immunity induced by allogeneic microglia in relation to neuronal retina transplantation.
    Ma N; Streilein JW
    J Immunol; 1999 Apr; 162(8):4482-9. PubMed ID: 10201985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Exp Eye Res; 1994 Jun; 58(6):719-28. PubMed ID: 7925711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
    Osawa H; Maruyama K; Streilein JW
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.